Cardiovascular Care of the Complex Client

Essential clinical vocabulary covering hemodynamic monitoring, heart failure management, inflammatory heart diseases, vascular emergencies, acute coronary syndrome, and rhythm/device management.

Preload

The volume of blood filling and stretching the ventricle at end-diastole; excess volume presents with crackles, jugular venous distension (JVD), and edema, and is decreased using diuretics and nitroglycerin or increased with IV fluids and blood.

Afterload

The systemic or pulmonary vascular resistance against which the ventricle must contract to eject blood; when excessively high, the heart works harder and cardiac output falls, requiring reduction with vasodilators or ACEI/ARNI.

Contractility

The intrinsic mechanical squeeze and force of ventricular myocardial contraction independent of loading conditions; poor contractility leads to cool, pale extremities, oliguria, and confusion, treated using inotropes such as dobutamine, milrinone, or digoxin.

Arterial Line

An invasive catheter placed into a peripheral artery (commonly the radial artery) connected to a transducer system to obtain continuous real-time arterial blood pressure and mean arterial pressure (MAP) measurements.

Phlebostatic Axis

The anatomical external reference point located at the 4th intercostal space (ICS) at the mid-axillary line (mid-point of the anterior-posterior chest wall), representing the level of the atria for leveling and zeroing hemodynamic pressure transducers.

Over-damped Waveform

A blunted hemodynamic tracing characterized by a flattened waveform and loss of the dicrotic notch, producing a falsely low systolic blood pressure reading; resolved by flushing the line, removing air or clots, checking for tubing kinks, and maintaining the pressure bag at $300\,\text{mm Hg}$.

Transducer Height Artifact

A measurement error in hemodynamic monitoring where placing the transducer below the phlebostatic axis produces falsely high pressure values, whereas positioning it above the axis produces falsely low pressure values.

Mean Arterial Pressure (MAP)

The average pressure in the arterial tree delivering perfusion to vital organs across the cardiac cycle, requiring a threshold of $\ge 65\,\text{mm Hg}$ to sustain organ perfusion (normal range $70\text{--}100\,\text{mm Hg}$), calculated as $\text{MAP} \approx (\text{SBP} + 2 \times \text{DBP}) \div 3$.

Central Venous Pressure (CVP)

The hydrostatic pressure measured in the superior vena cava or right atrium (normal range $2\text{--}6\,\text{mm Hg}$) reflecting right ventricular end-diastolic pressure and right-sided preload.

Pulmonary Artery Catheter Waveforms

The sequence of characteristic pressure wave patterns seen during catheter passage through the heart: right atrium (low, gentle waves, $0\text{--}8\,\text{mm Hg}$), right ventricle (tall peaks with diastolic pressure near $0\,\text{mm Hg}$), pulmonary artery (systolic peaks with stepped-up diastolic pressure, $8\text{--}15\,\text{mm Hg}$), and wedge/PAOP (low, undulating trace reflecting left atrial pressure).

Pulmonary Artery Occlusion Pressure (PAOP / Wedge)

The invasive pressure measurement obtained by briefly inflating the balloon tip of a pulmonary artery catheter (normal range $6\text{--}12\,\text{mm Hg}$) to assess left-sided ventricular preload and left ventricular end-diastolic pressure.

Systolic Heart Failure (HFrEF)

Heart failure with reduced ejection fraction ($\le 40\%$) characterized by impaired ventricular contractility ('weak pump') and inability to effectively eject blood during systole, frequently resulting from myocardial infarction.

Diastolic Heart Failure (HFpEF)

Heart failure with preserved ejection fraction ($\ge 50\%$) characterized by stiff, noncompliant ventricular myocardium that cannot adequately relax and fill during diastole, predominantly seen in older adults, females, and patients with hypertension, obesity, or diabetes.

Left-Sided Heart Failure

Failure of the left ventricle to pump forward output, causing blood to back up into the pulmonary circulation and manifesting as dyspnea, orthopnea, bilateral pulmonary crackles, an $S_3$ gallop, pink frothy sputum, decreased $\text{SpO}_2$, and hypoxemic confusion.

Right-Sided Heart Failure

Failure of the right ventricle leading to retrograde systemic venous congestion, characterized by jugular venous distension (JVD), dependent peripheral pitting edema, rapid weight gain, hepatomegaly, ascites, and anorexia.

Dilated Cardiomyopathy (DCM)

A myocardial disorder defined by ventricular chamber enlargement, dilation, and thinned walls, resulting in severely impaired systolic squeeze ('weak pump') and reduced ejection fraction.

Hypertrophic Cardiomyopathy (HCM)

A genetic myocardial disorder marked by marked asymmetrical ventricular wall hypertrophy, reducing chamber compliance and luminal volume, thereby acting as a primary cause of diastolic ventricular filling impairment ('stiff pump').

Restrictive Cardiomyopathy (RCM)

A form of cardiomyopathy characterized by rigid, stiff ventricular walls that resist diastolic ventricular stretching and filling while maintaining relatively preserved wall thickness and systolic contractility.

Guideline-Directed Medical Therapy (GDMT)

The four foundational medication classes proven to reduce morbidity and mortality in systolic heart failure (HFrEF): ARNI/ACEI/ARB, evidence-based $\beta$-blockers, mineralocorticoid receptor antagonists (MRAs), and SGLT2 inhibitors.

Angiotensin Receptor-Neprilysin Inhibitor (ARNI)

A drug combination (sacubitril/valsartan) that simultaneously blocks angiotensin II type 1 receptors and inhibits neprilysin to augment natriuretic peptides; contraindicated within 36 hours of an ACE inhibitor due to severe angioedema risk.

Mineralocorticoid Receptor Antagonist (MRA)

An aldosterone antagonist (e.g., spironolactone, eplerenone) used in heart failure management to block cardiac remodeling; requires monitoring and withholding if serum $\text{K}^+ > 5.5\,\text{mEq/L}$ or creatinine significantly rises.

SGLT2 Inhibitor

An oral agent (e.g., empagliflozin, dapagliflozin) that lowers hospitalizations and mortality across systolic (HFrEF) and diastolic (HFpEF) heart failure; requires screening for genital mycotic infections and holding during acute illness to prevent euglycemic DKA.

Pericarditis

Inflammation of the pericardial sac characterized by sharp, pleuritic chest pain that worsens when supine or taking deep breaths and improves upon sitting upright and leaning forward, accompanied by a pericardial friction rub and widespread ST elevation.

Myocarditis

Inflammation of the heart muscle, typically following a viral illness by $1\text{--}2\,\text{weeks}$ in young adults, presenting with chest pain, fatigue, heart failure cues, dysrhythmias, and elevated troponin; requires complete cessation of strenuous athletics for $3\text{--}6\,\text{months}$.

Infective Endocarditis (IE)

Microbial infection of the endocardium or heart valves manifested by fever, new or changing murmurs, and peripheral lesions (splinter hemorrhages, Janeway lesions, Osler nodes); diagnosed with 3 separate sets of blood cultures obtained prior to broad-spectrum IV antibiotics.

Beck's Triad

The classic trio of physical signs signaling cardiac tamponade: systemic hypotension, jugular venous distension (JVD), and muffled or distant heart sounds.

Pulsus Paradoxus

An abnormal inspiratory drop in systolic blood pressure greater than $10\,\text{mm Hg}$, indicating severe external pericardial restriction to ventricular filling such as in cardiac tamponade.

Hypertensive Emergency

An acute, severe blood pressure elevation ($>180/120\,\text{mm Hg}$) accompanied by new or deteriorating acute target-organ damage (brain, heart, or kidneys), requiring ICU admission and titratable IV drips to lower blood pressure by $\le 25\%$\ within the first hour.

Abdominal Aortic Aneurysm (AAA)

A permanent localized dilation of the abdominal aorta (most frequently infrarenal), commonly asymptomatic until discovery via screening ultrasound (recommended in men aged $65\text{--}75\,\text{years}$ with a smoking history) or presenting with a pulsatile abdominal mass and bruit.

Aortic Dissection

A life-threatening vascular emergency caused by an intimal tear in the aortic wall allowing blood to split the media, presenting with sudden excruciating 'tearing' chest or back pain, pulse deficits, and an arm BP discrepancy $>20\,\text{mm Hg}$; managed with IV $\beta$-blockers first to control heart rate before vasodilators are given.

Dual Antiplatelet Therapy (DAPT)

The concurrent administration of aspirin and an oral $\text{P2Y}_{12}$ inhibitor (clopidogrel, ticagrelor, or prasugrel) following percutaneous coronary intervention (typically for 12 months) to prevent catastrophic stent thrombosis.

Heparin-Induced Thrombocytopenia (HIT)

An immune-mediated prothrombotic complication of heparin exposure characterized by a $\ge 50\%$\ drop in platelet count typically between days 5 and 10 of therapy, requiring immediate cessation of all heparin products and initiation of a non-heparin anticoagulant.

Adenosine

An ultra-short-acting AV nodal blocking agent indicated for stable supraventricular tachycardia (SVT), administered as a rapid IV push ($6\,\text{mg}$ followed by a $20\,\text{mL}$ saline flush, with a repeat dose of $12\,\text{mg}$ if required), causing transient chemical asystole.

Synchronized Cardioversion

The delivery of a timed, low-to-moderate energy electrical shock synchronized with the R wave of the QRS complex to terminate unstable tachydysrhythmias with a pulse (e.g., rapid AF, atrial flutter, SVT, or monomorphic VT).

Defibrillation

The immediate delivery of an unsynchronized high-energy electric shock to depolarize the entire myocardium simultaneously, indicated exclusively for pulseless ventricular tachycardia (pVT) and ventricular fibrillation (VF).

Failure to Pace

A pacemaker malfunction in which the device fails to deliver an electrical stimulus when due, recognized on ECG telemetry by absent pacer spikes during bradycardia or prolonged pauses.

Failure to Capture

A pacemaker malfunction occurring when an emitted pacing spike fails to depolarize the targeted chamber, evidenced on ECG by the presence of a pacer spike not followed by an evoked P wave or QRS complex.

Pacemaker Undersensing

A pacemaker malfunction wherein the generator fails to detect the patient's intrinsic electrical activity, causing the pacer to discharge asynchronously and drop spikes on or after intrinsic beats, creating an R-on-T dysrhythmia risk.

Pacemaker Oversensing

A pacemaker malfunction wherein non-cardiac signals (such as muscle fasciculations or electrical interference) or tall T waves are inappropriately sensed as intrinsic cardiac beats, leading the pacer to withhold necessary pacing pulses.

Implantable Cardioverter-Defibrillator (ICD)

An electronic device implanted subcutaneously or subpectoral with leads inside the heart that continuously monitors cardiac rhythm and delivers internal antitachycardia pacing or defibrillation shocks to abort sustained VT and VF in patients at risk of sudden cardiac arrest.